Screener
Cronos Group CRON Cannabis extracts — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cronos Group in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Cronos Group’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001656472-26-000051
FAQ
- What is Cronos Group's cannabis extracts — net revenue?
- Cronos Group (CRON) reported cannabis extracts — net revenue of $13.77M in Q2 2026.
- How has Cronos Group's cannabis extracts — net revenue changed year-over-year?
- Cronos Group's cannabis extracts — net revenue increased by 64.8% year-over-year, from $8.36M to $13.77M.
- What is the long-term trend for Cronos Group's cannabis extracts — net revenue?
- Over 3 years (2022 to 2025), Cronos Group's cannabis extracts — net revenue has grown at a 60.4% compound annual growth rate (CAGR), from $9.14M to $37.7M.
- What does cannabis extracts — net revenue mean?
- This metric represents the total revenue generated from the sale of cannabis extract products after accounting for returns, discounts, and allowances. It serves as a key indicator of the market demand and commercial success of a company's concentrated cannabis product portfolio. Tracking this figure helps investors evaluate the growth trajectory and competitive positioning of the extracts segment relative to broader product offerings.
Ask your AI about Cronos Group's cannabis extracts — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude